TL
ABBV icon

TrueWealth LLC’s AbbVie ABBV Stock Holding History

TrueWealth LLC’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$166K Buy
1,690
+182
+12% +$16K 0.07% 153
2020
Q1 		$115K Hold
1,508
– – 0.06% 176
2019
Q4 		$134K Hold
1,508
– – 0.05% 177
2019
Q3 		$114K Sell
1,508
-163
-10% -$11.2K 0.05% 184
2019
Q2 		$122K Sell
1,671
-57
-3% -$4.48K 0.05% 181
2019
Q1 		$139K Buy
1,728
+59
+4% +$4.83K 0.06% 165
2018
Q4 		$154K Buy
1,669
+278
+20% +$24.4K 0.08% 149
2018
Q3 		$132K Buy
1,391
+1
+0.1% +$95 0.06% 174
2018
Q2 		$129K Buy
1,390
+1
+0.1% +$98 0.06% 174
2018
Q1 		$132K Buy
1,389
+86
+7% +$9.45K 0.07% 163
2017
Q4 		$126K Buy
+1,303
New +$123K 0.06% 185

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

TrueWealth LLC's ABBV Position: Q2 2020 in Review

TrueWealth LLC increased its AbbVie (ABBV) stake by 12% in Q2 2020, buying an estimated $16K and bringing the position to 1,690 shares worth $166K. The position accounts for 0.07% of the portfolio, ranked #153.

TrueWealth LLC first reported a position in ABBV in Q4 2017 and has held it in 11 quarters since. 2,412 funds tracked by Wall St. Rank hold ABBV as of Q2 2020.

  • TrueWealth LLC held 1,690 shares of AbbVie worth $166K as of Q2 2020.
  • TrueWealth LLC bought 182 AbbVie shares in Q2 2020, an estimated $16K.
  • AbbVie made up 0.07% of TrueWealth LLC's portfolio in Q2 2020, its #153 holding.
  • TrueWealth LLC first reported a position in AbbVie in Q4 2017 and has held it in 11 quarters since.
  • 2,412 funds tracked by Wall St. Rank held AbbVie as of Q2 2020.

Based on TrueWealth LLC's 13F filing for Q2 2020, filed 15 Jul 2020.